John Kolstoe, MD
Rheumatology · Bemidji, MNNPI 1124043229
Payments from drug & device makers
Across 545 payments — averaging $15.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- Amgen$1K
- Novartis$823
- AstraZeneca$683
- Lilly USA, LLC$330
- E.r. Squibb & Sons, L.L.C.$291
- plus $2K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 260 | $2,648 |
| Amgen(2 entities) | 69 | $1,397 |
| Novartis | 31 | $823 |
| AstraZeneca(2 entities) | 35 | $683 |
| Lilly USA, LLC | 12 | $330 |
| E.r. Squibb & Sons, L.L.C. | 15 | $291 |
| UCB, Inc. | 10 | $286 |
| AbbVie | 20 | $284 |
| ANI Pharmaceuticals, Inc. | 12 | $221 |
| Boehringer Ingelheim | 9 | $189 |
| Fresenius Kabi USA, LLC | 9 | $188 |
| Mallinckrodt Hospital Products Inc. | 9 | $185 |
| Radius Health, Inc. | 9 | $173 |
| Aurinia Pharma U.S., Inc. | 6 | $168 |
| Organon | 6 | $114 |
| Pfizer | 7 | $100 |
| Sobi, Inc | 5 | $93 |
| Sandoz | 4 | $63 |
| Alvogen Inc | 4 | $61 |
| Actelion Pharmaceuticals US, Inc. | 2 | $40 |
| Bioventus LLC | 2 | $37 |
| GSK | 3 | $37 |
| Sanofi | 2 | $33 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $21 |
| Mylan Institutional Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
How this compares
$8,524 in reported general payments places this provider in the 80th percentile of 121 rheumatology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Bemidji
- Elena MyasoedovaRochester$1.5M
- David RidleyEagan$1.2M
- Asim KhanMaple Grove$1.2M
- Elvia Moreta FreireEagan$799K
- Ashima MakolRochester$417K
- Uma ThanarajasingamRochester$399K
- Parastoo FazeliMinneapolis$320K
- Kenneth WarringtonRochester$233K
- Jerry MolitorMinneapolis$231K
- Cornelia WeyandRochester$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.